Assenagon Asset Management
NXTC icon

Assenagon Asset Management’s NextCure NXTC Stock Holding History

Assenagon Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,109
Closed -$117K – 1418
2024
Q3 		$117K Sell
7,109
-8,265
-54% -$152K ﹤0.01% 1342
2024
Q2 		$293K Sell
15,374
-20,186
-57% -$393K ﹤0.01% 1329
2024
Q1 		$952K Buy
+35,560
New +$613K ﹤0.01% 1067
2023
Q3 		– Sell
-3,660
Closed -$79.1K – 1442
2023
Q2 		$79.1K Buy
+3,660
New +$72.1K ﹤0.01% 1303
2022
Q3 		– Sell
-9,053
Closed -$511K – 1484
2022
Q2 		$511K Buy
+9,053
New +$473K ﹤0.01% 1223
2022
Q1 		– Sell
-10,488
Closed -$755K – 1521
2021
Q4 		$755K Buy
+10,488
New +$877K ﹤0.01% 1119
2021
Q3 		– Sell
-1,129
Closed -$109K – 1396
2021
Q2 		$109K Buy
+1,129
New +$116K ﹤0.01% 1166

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management's NXTC Position: Q4 2024 in Review

Assenagon Asset Management sold out of NextCure (NXTC) in Q4 2024, closing a stake of 7,109 shares — an estimated $117K sold.

Assenagon Asset Management first reported a position in NXTC in Q2 2021 and held it in 7 quarters. The position peaked at $952K in Q1 2024. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2024.

  • Assenagon Asset Management reported no remaining NextCure position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 7,109 NextCure shares in Q4 2024, an estimated $117K.
  • Assenagon Asset Management first reported a position in NextCure in Q2 2021 and held it in 7 quarters.
  • Assenagon Asset Management's NextCure position peaked at $952K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.